NEW YORK (GenomeWeb) – CareDx said today that it expects to report fourth quarter revenues of $12.3 million to $12.5 million, an increase of 13 percent to 15 percent over Q4 2016 revenues of $10.9 million.

Testing revenues for the quarter are expected to be $8.4 million to $8.6 million compared with $7.4 million in the same period in 2016, and product revenues are expected to be $3.7 million compared to $3.5 million in Q4 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.